Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique

Abstract In 2005, the Nigerian Federal Ministry of Health revised the treatment policy for uncomplicated malaria with the introduction of artemisinin-based combination therapies (ACTs). This policy change discouraged the use of Sulphadoxine-pyrimethamine (SP) as the second-line treatment of uncompli...

Full description

Bibliographic Details
Main Authors: Adeyemi T. Kayode, Fehintola V. Ajogbasile, Kazeem Akano, Jessica N. Uwanibe, Paul E. Oluniyi, Philomena J. Eromon, Onikepe A. Folarin, Akintunde Sowunmi, Dyann F. Wirth, Christian T. Happi
Format: Article
Language:English
Published: Nature Portfolio 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-80017-6
_version_ 1819200235658805248
author Adeyemi T. Kayode
Fehintola V. Ajogbasile
Kazeem Akano
Jessica N. Uwanibe
Paul E. Oluniyi
Philomena J. Eromon
Onikepe A. Folarin
Akintunde Sowunmi
Dyann F. Wirth
Christian T. Happi
author_facet Adeyemi T. Kayode
Fehintola V. Ajogbasile
Kazeem Akano
Jessica N. Uwanibe
Paul E. Oluniyi
Philomena J. Eromon
Onikepe A. Folarin
Akintunde Sowunmi
Dyann F. Wirth
Christian T. Happi
author_sort Adeyemi T. Kayode
collection DOAJ
description Abstract In 2005, the Nigerian Federal Ministry of Health revised the treatment policy for uncomplicated malaria with the introduction of artemisinin-based combination therapies (ACTs). This policy change discouraged the use of Sulphadoxine-pyrimethamine (SP) as the second-line treatment of uncomplicated falciparum malaria. However, SP is used as an intermittent preventive treatment of malaria in pregnancy (IPTp) and seasonal malaria chemoprevention (SMC) in children aged 3–59 months. There have been increasing reports of SP resistance especially in the non-pregnant population in Nigeria, thus, the need to continually monitor the efficacy of SP as IPTp and SMC by estimating polymorphisms in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes associated with SP resistance. The high resolution-melting (HRM) assay was used to investigate polymorphisms in codons 51, 59, 108 and 164 of the dhfr gene and codons 437, 540, 581 and 613 of the dhps gene. DNA was extracted from 271 dried bloodspot filter paper samples obtained from children (< 5 years old) with uncomplicated malaria. The dhfr triple mutant I51R59N108, dhps double mutant G437G581 and quadruple dhfr I51R59N108 + dhps G437 mutant haplotypes were observed in 80.8%, 13.7% and 52.8% parasites, respectively. Although the quintuple dhfr I51R59N108 + dhps G437E540 and sextuple dhfr I51R59N108 + dhps G437E540G581 mutant haplotypes linked with in-vivo and in-vitro SP resistance were not detected, constant surveillance of these haplotypes should be done in the country to detect any change in prevalence.
first_indexed 2024-12-23T03:29:01Z
format Article
id doaj.art-7ecd3ef5a9d34f1f890f91a36e6c1caa
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-23T03:29:01Z
publishDate 2021-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-7ecd3ef5a9d34f1f890f91a36e6c1caa2022-12-21T18:01:46ZengNature PortfolioScientific Reports2045-23222021-01-011111810.1038/s41598-020-80017-6Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting techniqueAdeyemi T. Kayode0Fehintola V. Ajogbasile1Kazeem Akano2Jessica N. Uwanibe3Paul E. Oluniyi4Philomena J. Eromon5Onikepe A. Folarin6Akintunde Sowunmi7Dyann F. Wirth8Christian T. Happi9African Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityInstitute of Advanced Medical Research and Training, College of Medicine, University of IbadanDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public HealthAfrican Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s UniversityAbstract In 2005, the Nigerian Federal Ministry of Health revised the treatment policy for uncomplicated malaria with the introduction of artemisinin-based combination therapies (ACTs). This policy change discouraged the use of Sulphadoxine-pyrimethamine (SP) as the second-line treatment of uncomplicated falciparum malaria. However, SP is used as an intermittent preventive treatment of malaria in pregnancy (IPTp) and seasonal malaria chemoprevention (SMC) in children aged 3–59 months. There have been increasing reports of SP resistance especially in the non-pregnant population in Nigeria, thus, the need to continually monitor the efficacy of SP as IPTp and SMC by estimating polymorphisms in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes associated with SP resistance. The high resolution-melting (HRM) assay was used to investigate polymorphisms in codons 51, 59, 108 and 164 of the dhfr gene and codons 437, 540, 581 and 613 of the dhps gene. DNA was extracted from 271 dried bloodspot filter paper samples obtained from children (< 5 years old) with uncomplicated malaria. The dhfr triple mutant I51R59N108, dhps double mutant G437G581 and quadruple dhfr I51R59N108 + dhps G437 mutant haplotypes were observed in 80.8%, 13.7% and 52.8% parasites, respectively. Although the quintuple dhfr I51R59N108 + dhps G437E540 and sextuple dhfr I51R59N108 + dhps G437E540G581 mutant haplotypes linked with in-vivo and in-vitro SP resistance were not detected, constant surveillance of these haplotypes should be done in the country to detect any change in prevalence.https://doi.org/10.1038/s41598-020-80017-6
spellingShingle Adeyemi T. Kayode
Fehintola V. Ajogbasile
Kazeem Akano
Jessica N. Uwanibe
Paul E. Oluniyi
Philomena J. Eromon
Onikepe A. Folarin
Akintunde Sowunmi
Dyann F. Wirth
Christian T. Happi
Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
Scientific Reports
title Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
title_full Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
title_fullStr Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
title_full_unstemmed Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
title_short Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique
title_sort polymorphisms in plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in nigerian children with uncomplicated malaria using high resolution melting technique
url https://doi.org/10.1038/s41598-020-80017-6
work_keys_str_mv AT adeyemitkayode polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT fehintolavajogbasile polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT kazeemakano polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT jessicanuwanibe polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT pauleoluniyi polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT philomenajeromon polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT onikepeafolarin polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT akintundesowunmi polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT dyannfwirth polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique
AT christianthappi polymorphismsinplasmodiumfalciparumdihydropteroatesynthetaseanddihydrofolatereductasegenesinnigerianchildrenwithuncomplicatedmalariausinghighresolutionmeltingtechnique